Immune Phenotype and Immune Checkpoint Inhibitors for the Treatment of Human Hepatocellular Carcinoma

Immune Phenotype and Immune Checkpoint Inhibitors for the Treatment of Human Hepatocellular Carcinoma

Immunotherapies are promising approaches for treating hepatocellular carcinomas (HCCs) refractory to conventional therapies. However, a recent clinical trial of immune checkpoint inhibitors (ICIs) revealed that anti-tumor responses to ICIs are not satisfactory in HCC cases. Therefore, it is critical...

Full description

Bibliographic Details
Main Authors: Naoshi Nishida, Masatoshi Kudo
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Cancers
Subjects:
hepatocellular carcinoma
molecular classification
immune phenotype
immune checkpoint inhibitor
stem cell marker
oncogenic signal
Online Access:https://www.mdpi.com/2072-6694/12/5/1274

Internet

https://www.mdpi.com/2072-6694/12/5/1274

Similar Items